Companies

ICU MEDICAL INC/DE

ICUI · CIK 0000883984 · operating

$150.58-0.16%Last updated Feb 27, 11:07 PM

Key Statistics

Valuation

Market Cap$3.72B
P/E
Fwd P/E16.36
PEG
P/S1.67
P/B1.75
EV/EBITDA15.33
EV/Rev2.13

Profitability

Gross Margin36.84%
Op. Margin1.92%
Net Margin0.03%
ROE0.03%
ROA0.02%
FCF Margin4.11%

Financial Health

Current Ratio2.39
Debt/Equity
Free Cash Flow$91.80M
Div. Yield

Growth & Other

Revenue Growth-6.33%
EPS Growth100.62%
Beta0.80
52W High$160.29
52W Low$107

About ICU MEDICAL INC/DE

ICU Medical develops, manufactures, and sells medical products for infusion therapy, vascular access, and vital care applications across global markets. The company's product portfolio includes needlefree connectors marketed under brands such as MicroClave and NanoClave, closed system transfer devices for hazardous drug preparation, catheter patency devices, and disinfection caps. It also manufactures IV therapy solutions including sodium chloride, dextrose, and balanced electrolyte solutions, along with specialized irrigation solutions for surgical and clinical use.

The company operates across several business segments encompassing infusion pumps under the Plum 360 and Plum Duo product lines, ambulatory and syringe infusion hardware, and IV medication safety software platforms including ICU Medical MedNet and LifeShield. Additional product categories include hemodynamic monitoring systems, anesthesia equipment, breathing circuits, temperature management solutions, and professional services offerings.

ICU Medical serves acute care hospitals, pharmaceutical wholesalers, ambulatory clinics, outpatient facilities, home health care providers, and long-term care institutions. The company operates with approximately 13,000 full-time employees and maintains headquarters in San Clemente, California. Founded in 1984, it maintains a global commercial presence supporting healthcare delivery across multiple care settings and geographies.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2025$0.03$0.03+100.6%
2024$-4.83$-4.83-292.7%
2023$-1.23$-1.23+60.5%
2022$-3.11$-3.11-165.6%
2021$4.74$4.86+291.7%
2020$1.21$1.24+26.0%
2019$0.96$1.00+366.7%
2018$-0.36$-0.36-115.5%
2017$2.33$2.47+331.5%
2016$0.54$0.58+63.6%
2015$0.33$0.34-28.3%
2014$0.46$0.48-46.5%
2013$0.86$0.89+4.9%
2012$0.82$0.86-34.9%
2011$1.26$1.29-43.5%
2010$2.23$2.27+26.0%
2009$1.77$1.80

Annual Reports (10-K) · 14 filings

Report DateFiledAccession Number
2025-12-312026-02-190000883984-26-000008SEC ↗
2024-12-312025-02-270000883984-25-000007SEC ↗
2023-12-312024-02-270000883984-24-000005SEC ↗
2022-12-312023-02-270000883984-23-000009SEC ↗
2021-12-312022-02-250000883984-22-000014SEC ↗
2020-12-312021-02-260000883984-21-000005SEC ↗
2019-12-312020-03-020000883984-20-000014SEC ↗
2018-12-312019-03-010000883984-19-000007SEC ↗
2017-12-312018-03-160000883984-18-000010SEC ↗
2016-12-312017-03-010000883984-17-000013SEC ↗
2015-12-312016-02-260000883984-16-000057SEC ↗
2014-12-312015-02-200000883984-15-000005SEC ↗
2013-12-312014-02-210000883984-14-000012SEC ↗
2012-12-312013-02-260000883984-13-000016SEC ↗